OSMI-4

Catalog No.S8910 Batch:S891001

Print

Technical Data

Formula

C27H26ClN3O7S2
Molecular Weight 604.09 CAS No. 2260791-14-6
Solubility (25°C)* In vitro DMSO 100 mg/mL (165.53 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5% DMSO 20% PEG300 3%Tween80 72%ddH2O
5.0mg/ml Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 200 μL of PEG300, mix evenly to clarify it; add 30 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 720 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description OSMI-4 is an inhibitor of O-linked N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) with EC50 of 3 μM in cells.
Targets
OGT [1]
(Cell-free assay)
3 μM(EC50)
In vitro

OSMI-4 reduces O-GlcNAc levels almost completely by 5 μM. A decrease in HCF-1 cleavage products and the appearance of uncleaved HCF-1 is observed in cells treated with OSMI-4. OSMI-4 is a kind of structure-based evolution of small molecule OGT inhibitors with low nanomolar binding affinities. OSMI-4 exhibits a ~3 μM EC50 in cells, making it especially attractive for probing OGT’s complex biology.[1]

Biological Activity

Description OSMI-4 is an inhibitor of O-linked N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) with EC50 of 3 μM in cells.
Targets
OGT [1]
(Cell-free assay)
3 μM(EC50)

Protocol (from reference)

Selleck's OSMI-4 has been cited by 5 publications

Inhibition of DNMT1 methyltransferase activity via glucose-regulated O-GlcNAcylation alters the epigenome [ Elife, 2023, 12e85595] PubMed: 37470704
FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer [ Sci Adv, 2023, 9(33):eadg7112] PubMed: 37595040
FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer [ Sci Adv, 2023, 9(33):eadg7112] PubMed: 37595040
O-GlcNAc transferase is important for homology-directed repair [ DNA Repair (Amst), 2022, 119:103394] PubMed: 36095925
A 2D and 3D cell culture protocol to study O-GlcNAc in sphingosine-1-phosphate mediated fibroblast contraction [ STAR Protoc, 2022, 3(1):101113] PubMed: 35118425

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.